Results 231 to 240 of about 27,114 (287)

Expression of interleukin-18 in primary Sjögren syndrome and its potential mechanisms with disease: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Deng Y, Wang Y, Cheng Y, Lei M, Luo Y, Gu W, Cai B, Li L, Zhang N.   +8 more
europepmc   +1 more source

Selective activation of antioxidant resources and energy deficiency in Marinesco-Sjögren syndrome fibroblasts as an adaptive biological response to Sil1 loss. [PDF]

Sci Rep
Panella V, Potenza F, Tatone C, Speranza L, Amicarelli F, Sallese M.   +5 more
europepmc   +1 more source

Particularities of Sjögren Syndrome in elderly. [PDF]

Tunis Med
Said F, Naceur I, Ben Achour T, Jeridi M, Ben Ghorbel I, Smiti M.   +5 more
europepmc   +1 more source

Invisible, Uncontrollable, Unpredictable: Illness Experiences in Women with Sjögren Syndrome. [PDF]

J Clin Med
Herrera A, Leiva L, Espinoza I, Ríos-Erazo M, Shakhtur N, Wurmann P, Rojas-Alcayaga G.   +6 more
europepmc   +1 more source

Hydroxychloroquine dose-dependently reduces the risk of incident diabetes in primary Sjögren syndrome patients on glucocorticoids: a nationwide population-based cohort study. [PDF]

Arthritis Res Ther
Chen WS, Hsu HC, Lin TM, Chang YS, Lin YC, Kuo TT, Shen YC, Chen SC, Chen JH, Lee HY, Chang CC.   +10 more
europepmc   +1 more source

Trazodone, dibenzoylmethane and tauroursodeoxycholic acid do not prevent motor dysfunction and neurodegeneration in Marinesco-Sjögren syndrome mice. [PDF]

PLoS One
Lavigna G, Grasso A, Pasini C, Grande V, Mignogna L, Restelli E, Masone A, Fracasso C, Lucchetti J, Gobbi M, Chiesa R.   +10 more
europepmc   +1 more source

Sjögren syndrome induced by anti PDL-1 treatment for TNBC: case report and review of literature. [PDF]

Front Immunol
Pellegrino C, D'Antonio C, Ierinò D, Onesti CE, Aschelter AM, Santini D, Mazzuca F.   +6 more
europepmc   +1 more source

[Sjogren's syndrome].

Medicinski pregled, 1977
M, Nektarijević, S, Jelić
openaire   +1 more source